Those who take Cannabidiol (CBD) – in oil, capsules or jellybeans – say that it works as an analgesic and anti-inflammatory, which calms anxiety and helps fight insomnia. It is an abundant component in cannabis that, however, does not ‘place’ because it lacks psychotropic effects. The sensation that it produces has been equated, for example, to the well-being after a yoga class. In permanently stressed societies, the CBD has become a consumer trend in the capitals of Europe and the United States, which has placed the molecule in the spotlight of industry, science and public administrations. Scientists believe that this substance has been elevated to the category of “magic pill” because it is very fashionable, but warn that not all the beneficial effects attributed to it are scientifically proven in humans and add that information on its components is lacking, posology and impact. Meanwhile, the industry (pharmaceutical, food, and cosmetics) promotes dozens of products with CBD. And in the USA, where its consumption is minimal and is linked to medicinal cannabis users, the police have been withdrawing this product from the market for months.